Priority Date: 06.12.11 (CN 20111401307)

DAIDZEIN DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

  • Application ID: EP12855855
  • Status: GRANT OF PATENT INTENDED

Attorney

Company dna schiweck weinzierl koch gbr
no operation time available
Headquarter in München
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 232 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 06.12.2011 - Priority Date (CN 20111401307)
  • 13.06.2013 - Publication A1 (WO2013083014)
  • 15.10.2014 - Publication A1 (EP2789604)

IPC Classification